Last Updated on December 24, 2023 by The Health Master
New Delhi: Granules India Limited made an announcement stating that the US Food Drug Administration (USFDA) has given its approval to the company’s Abbreviated New Drug Application (ANDA).
The application was filed by Granules Pharmaceuticals, Inc. (GPI), which is a subsidiary of Granules India Limited.
The approved drug is called Acetaminophen and Ibuprofen Tablets, with a strength of 250 mg/125 mg, and it can be purchased over the counter (OTC).
The USFDA has confirmed that this drug is equivalent to Advil® Dual Action with Acetaminophen Tablets, which is manufactured by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC.
Granules India Limited plans to launch this product through its division called Granules Consumer Health (GCH).
Acetaminophen and Ibuprofen tablets are a type of medicine that can help relieve minor aches and pains caused by:
- Headaches,
- Toothaches,
- Backaches,
- Menstrual cramps,
- Muscle aches,
- Minor arthritis pain.
The company has received a total of 59 approvals from the US Food Drug Administration (USFDA) for Abbreviated New Drug Applications (ANDAs). Out of these, 57 approvals are final and two are tentative.
Based on market data from IRI, a company that tracks sales in various outlets, the combined sales of the brand Advil Dual Action with Acetaminophen tablets and store-brand versions in the United States was around $70 million in the past year.
USFDA gives tentative nod for Dolutegravir tablets for oral suspension
USFDA approves 1st OTC Daily Oral Contraceptive
USFDA gives nod for Sevelamer HCL tablets
USFDA gives nod to this Nasal spray for Vitamin B12 deficiency
Pharma company penalised Rs 45 lakh for pollution
NABL: Awareness on accreditation for Drugs and Pharma Testing Laboratories
USFDA declines to approve this Parkinson’s drug
USFDA gives tentative nod for Dolutegravir tablets for oral suspension
USFDA issues Form 483 with one observation to Gland Pharma: Hyderabad
USFDA approves 1st OTC Daily Oral Contraceptive
Drug recall: Dronabinol Capsules, Ziprasidone HCL Capsules recalled due to this reason
Pharma Companies challenge Govt’s Ban on Pre-1988 FDCs
India Pharma Industry is leading market for USFDA Authorizations
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
